publication . Preprint . 2021

Cluster of COVID-19 in northern France: A retrospective closed cohort study

Arnaud Fontanet; Laura Tondeur; Yoann Madec; Rebecca Grant; Camille Besombes; Nathalie Jolly; Sandrine Fernandes Pellerin; Marie-Noëlle Ungeheuer; Isabelle Cailleau; Lucie Kuhmel; ...
Open Access English
  • Published: 19 Feb 2021
  • Publisher: HAL CCSD
  • Country: France
Abstract
<jats:title>Summary</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>The Oise department in France has been heavily affected by COVID-19 in early 2020.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Between 30 March and 4 April 2020, we conducted a retrospective closed cohort study among pupils, their parents and siblings, as well as teachers and non-teaching staff of a high-school located in Oise. Participants completed a questionnaire that covered history of fever and/or respiratory symptoms since 13 January 2020 and had blood tested for the presence of anti-SARS-CoV-2 antibodies. The infection attack rate (IAR) was define...
Persistent Identifiers
Subjects
free text keywords: [SDV]Life Sciences [q-bio], [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Herd immunity, Anosmia, medicine.symptom, medicine, Ageusia, Coronavirus disease 2019 (COVID-19), business.industry, business, Case fatality rate, Internal medicine, medicine.medical_specialty, Confidence interval, Attack rate, Cohort study
Funded by
ANR| INCEPTION
Project
INCEPTION
Institut Convergences pour l’étude de l’Emergence des Pathologies au Travers des Individus et des populatiONs
  • Funder: French National Research Agency (ANR) (ANR)
  • Project Code: ANR-16-CONV-0005
Communities
COVID-19
medRxiv
Preprint . 2020
Provider: medRxiv
Hal-Diderot
Preprint . 2021
Provider: Hal-Diderot
HAL-Inserm
Preprint . 2021
Provider: HAL-Inserm
17 references, page 1 of 2

1. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). In: World Health Organization/Newsroom [website]. Geneva: World Health Organization; 2020 (https://www.who.int/news-room/detail/30-01- 2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergencycommittee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov), accessed 29 March 2020).

Bernard Stoecklin S, Rolland P, Silue Y et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020 Feb;25(6).

Verity R, Okell LC, Dorigatti I et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis 2020 March 30.

Wölfel R, Corman VM, Guggemos W et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020. https://doi.org/10.1038/s41586-020-2196-x Okba NMA, Muller MA, Li W et al. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients. Emerg Infect Dis 2020 April 8;26(7).

7. Zhao J, Yuan Q, Wang H et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis 2020 March 28.

Bi Q, Wu Y, Mei S, et al. Epidemiology and transmission of COVID-19 in Shenzhen China: analysis of 391 cases and 1,286 of their close contacts. medRxiv 2020; published online March 19.

DOI:10.1101/2020.03.03.20028423 (preprint).

Gudbjartsson DF, Helgason A, Jonsson H, et al. Spread of SARS-CoV-2 in the Icelandic Population. N Engl J Med. 2020 Apr 14. doi: 10.1056/NEJMoa2006100. [Epub ahead of print]

10. COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, Korea Centers for Disease Control and Prevention. Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea. Osong Public Health Res Perspect 2020; 11(2): 85-90.

11. CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children - United States, February 12- April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426. doi: 10.15585/mmwr.mm6914e4.

12. Menni C, Valdes A, Freydin MB et al. Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection. medRxiv 2020; published online April 07. DOI:10.1101/2020.04.05.20048421 (preprint).

13. Bénézit F, Le Turnier P, Declercq C et al. Hyposmia and hypogeusia are discriminant features for the diagnosis of COVID-19 in patients with influenza-like illness. Lancet Infect Dis (accepted manuscript).

14. Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID19 in Wuhan, China: a retrospective cohort study. Lancet 2020 March 28;395(10229):1054-62.

15. CDC COVID-19 Response Team Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12- March 28, 2020 MMWR; April 3, 2020; 69:382-6.

16. Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 2020; 367: 1444-8.

17 references, page 1 of 2
Any information missing or wrong?Report an Issue